Halozyme Therapeutics, Inc. Share Price & Technical Analysis
HALO · $68.32 (-0.29%)
Healthcare / Biotechnology
$68.32
-0.29%
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeut…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
8% return in May, 3% avg return in past 3 year May month.
1% return in 2026, 11% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 6% | -3% | -7% | -2% | 8% | – | – | – | – | – | – | – | 1% |
| 25 | 17% | 7% | 8% | -4% | -8% | -7% | 16% | 22% | 2% | -13% | 8% | -7% | 43% |
| 24 | -8% | 17% | 2% | -6% | 15% | 18% | 6% | 15% | -10% | -11% | -13% | -1% | 24% |
| 23 | -9% | -7% | -20% | -16% | 1% | 11% | 19% | -1% | -11% | -11% | 15% | -5% | -33% |
| 22 | -13% | 3% | 12% | 0% | 14% | -5% | 11% | -16% | -2% | 20% | 19% | 0% | 43% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 that facilitates subcutaneous (SC) administration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; and XYOSTED, an injection for SC administration of testosterone replacement therapy. The company also provides Herceptin (trastuzumab) under the brand name Herceptin Hylecta; and Phesgo to treat breast cancer; Mabthera SC for chronic lymphocytic leukemia treatment; Tecentriq SC for IV infusion; Ocrevus SC for multiple sclerosis; HYQVIA to treat primary immunodeficiency disorders; DARZALEX to treat amyloidosis, and smoldering and multiple myeloma; epinephrine Injection to treat allergic reactions; nivolumab and relatlimab to treat metastatic or unresectable melanoma; teriparatide injections; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. It has collaborations and licensing agreements with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc.; Takeda Pharmaceuticals International AG and Baxalta US Inc.; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol Myers Squibb Company; argenx BVBA; ViiV Healthcare; Chugai Pharmaceutical Co., Ltd.; Acumen Pharmaceuticals, Inc.; Merus N.V.; and Skye Bioscience, Inc. The company was founded in 1998 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$8.64B
P/E ratio
28.48
52W high
$82.22
52W low
$51.06
Volume
10,83,153
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Halozyme Therapeutics, Inc. share price today?
- Halozyme Therapeutics, Inc. (HALO) last traded around $68.32 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does HALO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for HALO. Download the app for real-time alerts.
- How can I analyze Halozyme Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.